Brain Meningioma Treatment Guidelines

Diagnostic Imaging

• MRI with contrast is the standard diagnostic imaging modality for meningiomas, providing detailed characterization of the lesion and surrounding structures, as recommended by the American College of Radiology 1
• Typical MRI features include homogeneous dural-based enhancement, presence of a dural tail, CSF cleft between tumor and brain, and possible intratumoral calcifications, according to the American College of Radiology 1
• Somatostatin receptor (SSTR) PET imaging should be considered when tumor extension is unclear or for differentiation between recurrence and post-treatment changes, as suggested by the European Journal of Nuclear Medicine and Molecular Imaging 2, 3

Treatment Decision Algorithm

• The National Comprehensive Cancer Network recommends complete surgical resection as the treatment of choice for most brain meningiomas, with additional treatment options including observation, radiation therapy, and in select cases, peptide receptor radionuclide therapy (PRRT) 4
• Asymptomatic small meningiomas (<30 mm) should be observed, or surgery if accessible and potential neurological consequences exist, as recommended by the National Comprehensive Cancer Network 4
• Symptomatic small meningiomas (<30 mm) should be treated with surgery if accessible, followed by radiation therapy (RT) if WHO grade 3 or if incomplete resection, according to the National Comprehensive Cancer Network 4

Surgical Management

• Complete resection of meningiomas with removal of dural attachment is the optimal treatment when feasible, as recommended by the British Journal of Neurosurgery 5
• Modern surgical techniques including image-guided surgery (frameless stereotaxy) improve precision and may reduce surgical side effects, according to the British Journal of Neurosurgery 5

Radiation Therapy Options

• External beam radiation therapy (EBRT) is indicated for WHO grade 3 (malignant) meningiomas after surgery, as recommended by the National Comprehensive Cancer Network 4
• EBRT is also indicated for subtotally resected WHO grade 2 (atypical) meningiomas, according to the National Comprehensive Cancer Network 4

Advanced Treatment Options

• Peptide receptor radionuclide therapy (PRRT) using radiolabeled somatostatin receptor ligands shows promising results for treatment-refractory meningiomas, as reported by the European Journal of Nuclear Medicine and Molecular Imaging 2, 3
• SSTR PET imaging should be performed prior to PRRT to confirm target expression, as suggested by the European Journal of Nuclear Medicine and Molecular Imaging 2, 3

Post-Treatment Surveillance

• For WHO grade 1 meningiomas, MRI without and with contrast every 6-12 months is recommended, as suggested by the American College of Radiology 1
• SSTR PET may be useful in distinguishing tumor recurrence from post-treatment changes, according to the European Journal of Nuclear Medicine and Molecular Imaging 2, 3

MRI for Meningioma Management

Diagnostic Imaging Requirements

• MRI without and with IV contrast is the gold standard for evaluating meningiomas, providing detailed characterization of the lesion and surrounding structures 6, 7
• Typical MRI features include homogeneous dural-based enhancement, presence of a dural tail, CSF cleft between tumor and brain, and possible intratumoral calcifications visualized with SWI sequences 7

Advanced Imaging Options

• MR perfusion may be useful as an adjunct tool for meningioma grading, as meningiomas are highly vascular tumors 6, 7
• Functional MRI (fMRI) may be beneficial in specific cases where the meningioma is near eloquent brain areas to help preserve neurological function 7
• When tumor extension is unclear on conventional MRI, somatostatin receptor (SSTR) PET imaging provides superior detection sensitivity 8

Treatment Planning and Surveillance

• If treatment is planned, MRI should be performed within 2 weeks prior to any intervention as baseline for disease monitoring and response assessment 9
• The postradiotherapy MRI should be considered the "new baseline" rather than the postsurgical MRI for ongoing surveillance 7

Special Considerations

• MRI findings that should alert clinicians to the possibility of a meningioma mimic include marked T2-hypo- or hyperintensity, absence of a dural tail, and a dural displacement sign 7

Management of Calcified Meningiomas

Diagnostic Characteristics

• Calcifications are common in meningiomas, occurring in up to 50% of cases, and are more frequently observed in pediatric meningiomas 10, 11

Treatment Decision Algorithm

• Asymptomatic, incidentally discovered calcified meningiomas can be managed with observation, especially if located in eloquent, deep, or brainstem areas 12
• Asymptomatic, incidentally discovered calcified meningiomas can be managed with observation, especially if the patient has advanced age or significant comorbidities 10

Surgical Approach

• Complete surgical resection is the treatment of choice for symptomatic calcified meningiomas 10
• Surgery should be considered when the meningioma causes neurological symptoms 10
• Surgery should be considered when the meningioma shows evidence of growth on serial imaging 10
• Surgery should be considered when the meningioma is accessible with acceptable surgical risk 12

Surgical Considerations for Calcified Meningiomas

• Surgical risks are higher for deep-seated calcified meningiomas with 5-18% postoperative morbidity 12
• Surgical risks are higher for brainstem calcified meningiomas with significant early morbidity in nearly half of cases 12
• Surgical risks are higher for intraventricular calcified meningiomas with risk of significant blood loss 10

Special Considerations

• Recurrence rates for completely resected benign meningiomas can be up to 20% within 25 years, indicating the need for long-term follow-up 10

Alternative Treatment Options

• Radiation therapy or radiosurgery may be considered for calcified meningiomas in eloquent areas with unacceptable surgical risk 12
• Radiosurgery is not recommended for asymptomatic calcified meningiomas or those that are surgically accessible 12

MRI Sequences for Meningioma Visualization

Primary Imaging Recommendations

• The American College of Radiology recommends MRI without and with IV contrast as the gold standard for meningioma evaluation, with post-contrast T1-weighted imaging being the single most important sequence for tumor detection and characterization 13
• Contrast-enhanced T1-weighted sequences provide the best visualization of meningiomas, demonstrating homogeneous dural-based enhancement that defines these tumors 13

Optimal T1-Weighted Sequences

• 3D isotropic T1-weighted gradient echo sequences are preferred for high-resolution imaging and superior detection of small lesions 14, 15
• Post-contrast 3D T1-weighted sequences using fast spin-echo techniques are recommended over gradient echo sequences to reduce vascular signal artifact 16, 17

Essential Complementary Sequences

• Axial T2-weighted and FLAIR sequences are critical for demonstrating the CSF cleft between tumor and brain and evaluating vasogenic edema in adjacent parenchyma 13
• Post-contrast T2 FLAIR can enhance detection of leptomeningeal involvement in rare cases of meningioma with CSF dissemination 16, 17
• Susceptibility-Weighted Imaging (SWI) sequences detect intratumoral calcifications, which occur in up to 50% of meningiomas 13
• Diffusion-Weighted Imaging (DWI) provides information about tumor cellularity, though meningiomas typically show variable diffusion characteristics 13

Practical Imaging Protocol

• A standardized brain tumor imaging protocol recommends a sequence order including pre-contrast 3D T1-weighted gradient echo, axial 2D T2 FLAIR, axial 2D DWI, axial 2D T2-weighted, and post-contrast 3D T1-weighted gradient echo 14, 15, 16
• Total acquisition time is approximately 21-30 minutes on modern 3T systems 15

Determining the Primary Origin of a Large Meningioma

Imaging Approach to Identify Origin

• The primary origin of a large meningioma is determined by identifying its dural attachment site on contrast-enhanced MRI, as meningiomas arise from arachnoid cap cells of the meninges and maintain a characteristic connection to the dura at their site of origin 18, 19
• The dural attachment site visible on contrast-enhanced imaging indicates the primary origin, as meningiomas arise from arachnoid cells present in the meninges 20

Common Origin Sites in Adults Over 40

• Up to 90% of meningiomas are supratentorial in location 20
• Cerebral convexity is the most common location for meningiomas, followed by the parasagittal/falcine region and sphenoid wing 20
• Posterior fossa locations occur but are less frequent, and intraventricular meningiomas can occur without obvious dural attachment, making origin identification more challenging 20

Clinical Context Integration

• In adults over 40, meningiomas show female predominance (3:2), unlike pediatric cases 20
• Location-specific symptoms can provide clinical clues to origin: convexity tumors present with seizures, skull base tumors with cranial nerve deficits, and parasagittal tumors with motor deficits 20
• The American College of Radiology recommends considering CT without contrast as an adjunct to identify calcifications and hyperostosis, which can help confirm the primary attachment site 18

CT Detection of Meningiomas

Introduction to CT Capabilities

• The American College of Radiology recommends that CT can detect larger meningiomas, particularly those with calcifications, but it is significantly inferior to MRI for suspected meningiomas 21
• The American College of Radiology suggests that contrast-enhanced CT can show larger meningiomas with their characteristic dense enhancement pattern, though with less sensitivity than MRI 22

CT Limitations

• The American College of Radiology states that small lesions are frequently missed on CT, particularly when located in the internal auditory canal or cerebellopontine angle cistern, due to limited contrast resolution 22
• The American College of Radiology notes that CT is insensitive compared to MRI even with optimized techniques for detecting pituitary and parasellar pathology, which includes meningiomas in these regions 21
• The American College of Radiology indicates that cystic components may be confused with cerebrospinal fluid on CT 21

Appropriate Use of CT

• The American College of Radiology recommends that CT may be considered for surgical planning when it provides detailed osseous anatomy of the skull base and sphenoid sinus for trans-sphenoidal approaches 21
• The American College of Radiology suggests that CT with contrast may be used as a second-line option when MRI cannot be performed due to contraindications, though it will miss smaller lesions 22

Important Considerations

• The American College of Radiology advises against relying on CT alone for excluding meningioma, as negative CT does not rule out the diagnosis, particularly for smaller or non-calcified lesions 22

Imaging Recommendations for Incidental Calcified Extra‑Axial Lesions Suspected of Meningioma

Mandatory MRI for Initial Characterization

• The American College of Radiology states that MRI of the brain without and with intravenous contrast is the mandatory next imaging study for incidental calcified extra‑axial lesions because CT cannot reliably characterize these lesions or exclude meningioma mimics. 23

MRI Provides Definitive Diagnosis

• According to the American College of Radiology, MRI demonstrates classic meningioma features—including homogeneous dural‑based enhancement, a dural‑tail sign, a CSF cleft between tumor and brain, and confirmation of the extra‑axial location—thereby providing a definitive diagnosis. 23

Standardized MRI Protocol for Suspected Meningioma

• The American College of Radiology recommends a standardized MRI protocol that includes:

Baseline and Surveillance Imaging Using the Same Protocol

• The American College of Radiology advises that the baseline MRI protocol described above should be employed for the initial evaluation and for all follow‑up scans when monitoring incidental small calcified meningiomas. 23